Responders (n=123) | Low responders (n=66) | p Value | |
---|---|---|---|
Male (n (%)) | 47 (38.2) | 13 (19.7) | 0.01 |
Age (years) (mean±SD) | 59.5±10.8 | 60.6±11.3 | 0.53 |
Body mass index (kg/m2) (mean±SD) | 58.3±10.2 | 58.1±16.4 | 0.93 |
Current smoker (n (%)) | 39 (31.7) | 11 (16.7) | 0.04 |
Comorbidity (n (%)) | |||
Stroke | 14 (11.4) | 8 (12.1) | 1.00 |
Diabetes mellitus | 15 (12.2) | 4 (6.1) | 0.27 |
Hypertension | 61 (49.6) | 23 (34.8) | 0.07 |
Hyperlipidemia | 44 (35.8) | 23 (34.8) | 1.00 |
Ischemic heart disease | 3 (2.4) | 3 (4.5) | 0.42 |
Peripheral artery disease | 0 (0) | 2 (3.0) | 0.10 |
Medication (n (%)) | |||
Antiplatelet drugs | 0.12 | ||
Clopidogrel | 19 (15.4) | 6 (9.1) | |
Clopidogrel+aspirin | 95 (77.2) | 52 (78.8) | |
Clopidogrel+cilostazol | 4 (3.3) | 7 (10.6) | |
Clopidogrel+aspirin+cilostazol | 5 (4.1) | 1 (1.5) | |
Oral anticoagulant drug | 3 (2.7) | 2 (3.0) | 1.00 |
Proton pump inhibitor | 98 (79.7) | 45 (68.2) | 0.11 |
Statin | 26 (21.1) | 16 (24.2) | 0.76 |
Argatrovan (postoperative) | 39 (31.7) | 25 (37.9) | 0.48 |
Blood chemistry (mean±SD) | |||
Hemoglobin (g/mL) | 13.7±1.4 | 13.1±0.9 | <0.01 |
Platelet (104/μL) | 240±63 | 233±58 | 0.46 |
PT-INR | 0.97±0.14 | 0.97±0.15 | 0.86 |
APTT (%) | 99.2±24.5 | 96.2±20.6 | 0.38 |
eGFR (mL/min/1.73 m2) | 79.9±18.1 | 76.2±14.5 | 0.12 |
APTT, activated partial thromboplastin time; eGFR, estimated glomerular filtration rate; PT-INR, prothrombin time–international normalized ratio.